Ruby Pawankar Selected Research

Ruby Pawankar Research Topics

Disease

29	Hypersensitivity (Allergy) 04/2022 - 12/2008
29	Asthma (Bronchial Asthma) 01/2020 - 03/2002
13	Inflammation (Inflammations) 01/2021 - 12/2003
12	Allergic Rhinitis 01/2022 - 07/2003
12	Nasal Polyps (Nasal Polyp) 07/2011 - 02/2003
8	Rhinitis 11/2019 - 03/2002
5	Rhinosinusitis 03/2013 - 11/2006
4	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2005
4	Food Hypersensitivity (Food Allergy) 12/2021 - 02/2003
3	Hereditary Angioedemas 03/2022 - 12/2012
3	Eosinophilia 05/2013 - 04/2003
2	Exercise-Induced Allergies 01/2022 - 07/2020
2	Drug Hypersensitivity (Drug Allergy) 10/2020 - 01/2020
2	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2016 - 01/2015
2	Mycoses (Diseases, Fungus) 01/2012 - 01/2012
2	Hearing Loss (Hearing Impairment) 09/2011 - 01/2009
2	Fistula 09/2011 - 01/2009
2	Atopic Dermatitis (Atopic Eczema) 07/2011 - 01/2006
2	Otitis Media with Effusion 06/2009 - 04/2003
2	Allergic Fungal Sinusitis 11/2006 - 11/2006
1	Milk Hypersensitivity (Milk Allergy) 04/2022
1	Infections 01/2022
1	COVID-19 10/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Cicatrix (Scar) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Fever (Fevers) 01/2019
1	Obesity 01/2019
1	Kimura Disease 10/2017
1	Chronic Disease (Chronic Diseases) 02/2017
1	Confusion (Bewilderment) 01/2014
1	Rare Diseases (Rare Disease) 12/2012
1	Seasonal Allergic Rhinitis (Hay Fever) 04/2012
1	Tympanic Membrane Perforation 09/2011

Drug/Important Bio-Agent (IBA)

17	AllergensIBA 01/2022 - 03/2009
15	Immunoglobulin E (IgE)IBA 04/2022 - 02/2003
12	CytokinesIBA 02/2015 - 01/2005
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015 - 01/2008
4	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021 - 02/2003
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 11/2006
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 02/2003
4	Interleukin-4 (Interleukin 4)IBA 10/2017 - 01/2008
4	Thymic Stromal LymphopoietinIBA 02/2015 - 01/2010
4	Cytidine Triphosphate (CTP)IBA 09/2011 - 01/2009
4	Chemokine CCL17IBA 07/2011 - 06/2008
3	Pharmaceutical PreparationsIBA 10/2020 - 01/2020
3	Air Pollutants (Pollutants, Air)IBA 03/2020 - 09/2016
3	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2009
3	SteroidsIBA 04/2014 - 01/2012
3	Interleukin-5 (Interleukin 5)IBA 10/2011 - 04/2003
3	Messenger RNA (mRNA)IBA 07/2011 - 06/2008
3	LigandsIBA 03/2010 - 12/2007
3	Proteins (Proteins, Gene)FDA Link 03/2010 - 12/2008
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022 - 12/2013
2	Biological ProductsIBA 01/2021 - 11/2018
2	Contrast MediaIBA 10/2020 - 01/2020
2	InterleukinsIBA 02/2015 - 10/2011
2	Interleukin-17 (Interleukin 17)IBA 02/2015 - 10/2009
2	Fluticasone (Cutivate)FDA LinkGeneric 05/2013 - 03/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2013 - 03/2010
2	anti-IgE antibodiesIBA 04/2012 - 03/2002
2	AntigensIBA 04/2012 - 08/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2012 - 01/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2011 - 01/2007
2	Poly I-CIBA 01/2010 - 06/2009
2	Chemokine CCL5IBA 01/2006 - 03/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2003 - 02/2003
1	VenomsIBA 02/2020
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2020
1	Penicillins (Penicillin)FDA Link 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	Allopurinol (Remid)FDA LinkGeneric 01/2020
1	beta Lactam AntibioticsIBA 01/2020
1	HLA-B Antigens (HLA-B)IBA 01/2020
1	IceIBA 01/2019
1	Iron-Dextran Complex (InFed)FDA Link 01/2018
1	Vehicle Emissions (Emissions, Vehicle)IBA 09/2016
1	VaccinesIBA 01/2016
1	PrebioticsIBA 01/2016
1	Vitamin D FDA LinkGeneric 01/2016
1	Interleukin-13IBA 02/2015
1	Interleukin-33IBA 02/2015
1	Interleukin-22 (IL-22)IBA 02/2015
1	OzoneIBA 01/2015
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 04/2014
1	Salmeterol Xinafoate (Serevent)FDA Link 05/2013
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 04/2012
1	Monoclonal AntibodiesIBA 04/2012
1	IgE Receptors (Fc epsilon RI)IBA 10/2011
1	Chemokine CCL22IBA 07/2011

Therapy/Procedure

13	Therapeutics 03/2022 - 03/2002
11	Immunotherapy 04/2022 - 11/2009
2	Respiratory Therapy (Therapy, Respiratory) 01/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 11/2019 - 01/2014
1	Precision Medicine 01/2021
1	Contraindications 01/2021
1	Percutaneous Coronary Intervention 01/2020
1	Self Medication 01/2019
1	Wearable Electronic Devices 02/2017